BDBM50265533 2-({[(1S,5R,13R,14S,17S)-9,17-dihydroxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-yl]carbamoyl}methoxy)-N-(4-{2-[(methylcarbamoyl)methoxy]acetamido}butyl)acetamide::CHEMBL452991

SMILES CNC(=O)COCC(=O)NCCCCNC(=O)COCC(=O)N[C@H]1CC[C@@]2(O)[C@H]3Cc4cc(O)cc5O[C@@H]1[C@]2(CCN3C)c45

InChI Key InChIKey=LXFPQYIZOTVJFQ-UHFFFAOYSA-N

Data  2 KI  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50265533   

TargetGastrin/cholecystokinin type B receptor(Human)
University of Minnesota

Curated by ChEMBL
LigandPNGBDBM50265533(2-({[(1S,5R,13R,14S,17S)-9,17-dihydroxy-4-methyl-1...)
Affinity DataEC50:  572nMAssay Description:Activity at CCK2R-MOPR coexpressed in CHO cells co-transfected with delta-6-Galphaqi4-myr assessed as intracellular calcium release by FLIPRMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetMu-type opioid receptor(Human)
University of Minnesota

Curated by ChEMBL
LigandPNGBDBM50265533(2-({[(1S,5R,13R,14S,17S)-9,17-dihydroxy-4-methyl-1...)
Affinity DataKi:  29.8nMAssay Description:Displacement of [3H]DAMGO from mu opioid receptor expressed in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
University of Minnesota

Curated by ChEMBL
LigandPNGBDBM50265533(2-({[(1S,5R,13R,14S,17S)-9,17-dihydroxy-4-methyl-1...)
Affinity DataKi:  40.7nMAssay Description:Displacement of [3H]DAMGO from CCK2R-MOPR coexpressed in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed